Search
for
Sort by
Research 451–480 of 1000+
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- A study on dermatoses of pregnancy
- A clinical and histopathological study of cicatricial alopecia
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- Selected topics in pediatric hair loss
- Disorders of ovulation
- Dermatological Maifestations of Obesity
- Subject Index
- The Role of Sex Hormones in Skin Health
- Drug-Induced Skin, Nail and Hair Disorders
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Primary cicatricial alopecia
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Hidradenitis Suppurativa
- Analysis of hidradenitis suppurativa–linked mutations in four genes and the effects of PSEN1-P242LfsX11 on cytokine and chemokine expression in macrophages
- Is Propionibacterium acnes associated with hair casts and alopecia?
- Pilomatricoma arising at a BCG vaccination site
- Cicatricial (scarring) alopecia
- Guía clínica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo
- Topical Minoxidil
- Azelaic Acid in Dermatology: A Review of Its Mechanism of Action
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Folliculotropic mycosis fungoides
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours